Riskpilot← Back to searchSign inGet full accessCura Bäckenbottenmottagning AB
ABActiveOrg 5593380347Norr Mälarstrand 100General medical practice activities · NACE 8621Est. 20211-4 employees
Revenue 2024
SEK 3,9M
+253% vs 2023
EBITDA margin
19.0%
+398% vs 2023
Equity ratio
24.6%
Financial strength
Net profit 2024
SEK 378K
+245% vs 2023
| Revenue | SEK 3,9M | +253% |
| EBITDA | SEK 738K | +398% |
| Net profit | SEK 378K | +245% |
| Total assets | SEK 978K | +507% |
| Equity | SEK 240K | +275% |
| Employees | — | — |
Legal name
Cura Bäckenbottenmottagning AB
Org number
5593380347
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 oktober 2021
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva skönhetsvård, hårborttagning laser samt behandla inkontinens med hjälp av maskinen Emsella som tränar upp bäckenbotten
Address
Norr Mälarstrand 100
Phone
+46790471356
Email
jacob@leanlaser.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 1 253 | 1 101 | 3 884 |
| Staff expenses | — | — | −405 |
| EBITDA | 25 | −248 | 738 |
| Depreciation & amort. | −0 | −0 | −215 |
| EBIT | 25 | −248 | 523 |
| Net financials | — | −13 | −28 |
| Profit before tax | 25 | −261 | 422 |
| Tax | −6 | −0 | −45 |
| Net profit | 19 | −261 | 378 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 155 | 161 | 978 |
| Equity | 44 | −137 | 240 |
| Long-term debt | 0 | 250 | 224 |
| Short-term debt | 112 | 49 | 441 |
| Total debt | 112 | 299 | 665 |
EBITDA margin
19.0%
This company
15.8%
Market median
+20% vs market
20222024
Equity ratio
24.6%
This company
38.2%
Market median
-36% vs market
20222024
Return on equity
157.2%
This company
18.4%
Market median
+754% vs market
20222024
Net profit margin
9.7%
This company
8.1%
Market median
+20% vs market
20222024
Asset turnover
3.97×
This company
1.12×
Market median
+254% vs market
20222024
Debt / equity
3.07×
This company
0.62×
Market median
-395% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (5) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2025 – 2025 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cura Bäckenbottenmottagning AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jacob Jonas Dencker | Chief Executive Officer | 0 companies |
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Per Ture Dencker | Deputy Board Member | 0 companies |
| Gina Noori | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Petra Maria Nilsson Andersson | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |